Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
4.040
-0.150 (-3.58%)
At close: Jun 18, 2026, 4:00 PM EDT
4.170
+0.130 (3.22%)
After-hours: Jun 18, 2026, 5:42 PM EDT
Femasys Employees
As of December 31, 2025, Femasys had 54 total employees, including 51 full-time and 3 part-time employees. The number of employees decreased by 17 or -23.94% compared to the previous year.
Employees
54
Change (1Y)
-17
Growth (1Y)
-23.94%
Revenue / Employee
$44,017
Profits / Employee
-$229,674
Market Cap
12.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 54 | -17 | -23.94% | 51 | 3 |
| Dec 31, 2024 | 71 | 37 | 108.82% | 69 | 2 |
| Dec 31, 2023 | 34 | -2 | -5.56% | 32 | 2 |
| Dec 31, 2022 | 36 | 7 | 24.14% | 34 | 2 |
| Dec 31, 2021 | 29 | 3 | 11.54% | 27 | 2 |
| Jun 30, 2021 | 27 | - | - | 25 | 2 |
| Mar 31, 2021 | 26 | - | - | 24 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Nephros | 36 |
| NEXGEL | 19 |
| Zentek | 18 |
| Milestone Scientific | 15 |
FEMY News
- 14 days ago - Femasys Inc trading halted, news pending - TheFly
- 5 weeks ago - Femasys announces CE Mark approval for FemHSG Catheter - TheFly
- 5 weeks ago - Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter - GlobeNewsWire
- 5 weeks ago - Femasys Slides: Corporate presentation - Filings
- 6 weeks ago - Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Femasys Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Femasys Earnings release: Q1 2026 - Filings
- 6 weeks ago - Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete - GlobeNewsWire